Horizon Pharma (HZNP) PT Lifted to $30 at Mizuho

November 8, 2016 6:17 AM EST
Get Alerts HZNP Hot Sheet
Price: $20.15 +1.26%

Rating Summary:
    13 Buy, 2 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade HZNP Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Mizuho Securities analyst Irina Koffler reiterated a Buy rating and bumped her price target on Horizon Pharma (NASDAQ: HZNP) to $30.00 (from $29.00) following solid Q3 results and strong rebound in the stock.

Koffler commented, "HZNP had a strong move after 3Q:16, rebounding from the sector sell-off. There were no announcements to get us more bullish on the story but we still expect shares to advance following the election, and into the release of the FA data in late December. Potential contracting with ESRX could be another catalyst. We reiterate our Buy rating and raise PT to $30 from $29."

For an analyst ratings summary and ratings history on Horizon Pharma click here. For more ratings news on Horizon Pharma click here.

Shares of Horizon Pharma closed at $17.16 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Irina Koffler

Add Your Comment